Lung disease is the fourth leading cause of morbidity and mortality in the U.S. population. Although death rates from heart disease, cancer, and cerebrovascular disease have decreased in the past 10 years, death rates from chronic lower respiratory disease have not. Although tobacco use and traffic-related pollutants account for a portion of disease statistics, the precise etiology of lung disease remains unknown. A significant problem in assessing the contribution of individual chemicals or mixtures of chemicals to lung disease is related to the uncertainty of the use of animal models for human lung disease. Numerous chemicals, including naphthalene ([@b43-ehp-118-647]), trichloroethylene ([@b40-ehp-118-647]), and styrene ([@b22-ehp-118-647]), cause differential toxicity in two common rodent models, mice and rats, raising the question of relevance of these rodent models for human risk assessment.

Naphthalene administration results in highly selective necrosis of nonciliated bronchiolar epithelial cells of mice regardless of the route of administration. Inhaled concentrations of 2--5 ppm for 4 hr, well below the current occupational standard, cause detectable toxicity ([@b50-ehp-118-647]). In contrast, injury to airway epithelium of the rat does not occur at concentrations ≤ 100 ppm ([@b50-ehp-118-647]). The nasal epithelium of both rats and mice is highly sensitive to naphthalene administered either parenterally or by inhalation ([@b29-ehp-118-647]; [@b43-ehp-118-647]). Recent studies have demonstrated sensitivity of rat olfactory epithelium at concentrations similar to those in urban atmospheres (0.3 ppm) ([@b19-ehp-118-647]).

The species-, tissue-, and site-selective injury caused by naphthalene has been used to identify mechanisms associated with toxicity (for review, see [@b10-ehp-118-647]). Naphthalene undergoes metabolism by the cytochrome P450 monooxygenases to reactive metabolites that become bound covalently to tissue proteins. The primary P450 involved in metabolism in the mouse lung and rat nose appears to be cytochrome P450 2F (CYP2F); this protein has high affinity for naphthalene as a substrate (*K*~m,~ \~ 4 μM) with high catalytic turnover (104/min) ([@b47-ehp-118-647]). CYP2F orthologs found in the lungs of nonhuman primates (CYP2F5; [@b4-ehp-118-647]) and humans (CYP2F1; [@b38-ehp-118-647]) had little or no catalytic activity when expressed as recombinant enzyme ([@b28-ehp-118-647]). This was consistent with the finding that lung microsomes from monkeys and humans metabolized naphthalene to water-soluble metabolites at very low rates ([@b9-ehp-118-647]; [@b11-ehp-118-647]) and that dissected monkey airways generated metabolites very slowly ([@b5-ehp-118-647]). Because the initial step in the turnover of naphthalene is critical to toxicity, these data would indicate that monkeys and humans would be considerably less susceptible to naphthalene exposure than rodents. However, more recent data have shown that, although the rates of water-soluble metabolite formation are low, reactive metabolite protein binding occurs at similar levels in sensitive rodent tissues ([@b14-ehp-118-647]) and in dissected airways of monkeys ([@b5-ehp-118-647]).

Human exposure to naphthalene is nearly universal; the recent National Health and Nutrition Examination Survey studies demonstrated detectable levels of 1-naphthol glucuronide in the urine of all 2,785 subjects tested ([@b30-ehp-118-647]). However, epidemiologic studies have failed to establish a relationship between naphthalene exposure and any long-term health consequences in the respiratory tract. Either humans are not as susceptible to the compound as rodents are, or respiratory diseases are multifactorial in origin and epidemiologic studies have not been sufficiently powered to detect subtle contributions of naphthalene to the overall incidence of disease.

In the present study we focused on protein-bound metabolites in nasal epithelium of rats and rhesus macaques. In contrast to previous work showing 10- to 100-fold higher rates of naphthalene metabolism by dissected mouse airways compared with the rhesus airway ([@b5-ehp-118-647]; [@b42-ehp-118-647]), the present study shows that the rates of formation of covalently bound metabolites in rhesus nasal epithelium are similar to those in rat nasal epithelium, a target for naphthalene toxicity. This study also demonstrates some concordance in the adducted proteins identified in rat and monkey nasal epithelial incubations. We identified proteins involved in the unfolded protein response in incubations with rat but not monkey nasal epithelium. Proteins identified in the present work could serve as potential biomarker targets for studies in exposed human populations.

Materials and Methods
=====================

Animals
-------

All animal work was conducted under protocols approved by the University of California--Davis (UCD) Animal Use and Care Committee. Animals were treated humanely and with regard to alleviation of suffering. Male Sprague-Dawley rats (200--225 g body weight) were obtained from Harlan Laboratories (Indianapolis, IN) and housed in the UCD vivarium for at least 1 week before experimentation. Animals were euthanized with an overdose of pentobarbital, and olfactory and septal turbinates were removed. Ethmoturbinates and maxilloturbinates were obtained from eight male and seven female rhesus macaques through the California National Primate Research Center \[animal characteristics are available in Supplemental Material, Table 1 (doi:10.1289/ehp.0901333)\]. All rhesus macaque tissue was from animals euthanized for normal colony maintenance at the center.

Reagents
--------

We obtained \[1,4,5,8-^14^C\]naphthalene (specific activity 58 mCi/mmol) from Moravek Radiochemicals (Brea, CA) and checked purity (99%) by high-performance liquid chromatography. Protease inhibitor cocktail III, nondetergent sulfobetaine-195 (NDSB-195), benzamidine, 1,10-phenanthroline, aprotinin, pepstatin, and leupeptin were purchased from Calbiochem (La Jolla, CA). Rhinohide acrylamide/bisacrylamide was from Invitrogen (Carlsbad, CA), and Bio-Rad Protein Assay solution was purchased from Bio-Rad (Hercules, CA). We obtained immobilized pH gradient (IPG) buffers and narrow-range IPG Immobiline dry strips (18 cm) from GE Health Care (Piscataway, NJ). Unless otherwise stated, all reagents were molecular biology grade or better.

Tissue incubation and preparation
---------------------------------

Tissue was incubated in oxygenated Waymouth's medium deficient in sulfur amino acids (glutathione, cysteine, methionine) containing 250 μM naphthalene or 250 μM ^14^C-naphthalene at a specific activity of 1.10 × 10^5^ disintegrations per minute per nanomole. Incubations were performed for 2 hr at 37°C in a shaking water bath. For protein identification, we incubated tissue with unlabeled substrate.

After the incubation, tissues were rinsed with cold 5% dextrose and homogenized in lysis solution \[2 M thiourea, 7 M urea, 4% wt/wt 3-(3-cholamidopropyl)-dimethylammoniopropane sulfonate (CHAPS), 0.5% Triton X-100, 1% dithiothreitol, and 2% protease inhibitor cocktail\] using glass--glass homogenizers. Tissues were allowed to sit at room temperature for 1 hr after homogenization to allow further solubilization and denaturation of proteins. Insoluble proteins were removed by centrifugation (100,000 × *g* for 1 hr).

The tough, bony structure of primate turbinates dictated the use of modified procedures for protein recovery. Briefly, after the incubation, the incubation medium was transferred to a clean centrifuge tube. The tissue was washed with 5% dextrose to remove buffer salts, and fractions of the aqueous phase were combined. These samples were centrifuged to recover any tissue/cells removed, and the pellets were combined with the remaining cartilage containing the epithelium. Lysis buffer containing protease inhibitors was added, and the tube was agitated on a rotating shaker to dislodge cells.

Comparison of covalent binding levels
-------------------------------------

A portion (\~ 1 mg protein) of each sample (from rat or monkey nasal epithelium) incubated with ^14^C-naphthalene was dialyzed in 0.1% sodium dodecyl sulfate, 1 mM disodium EDTA at 4°C \[3,500 molecular weight (MW) cutoff Slide-A-Lyzers; Pierce, Rockford, IL\]. The dialysis solution was replaced with fresh solution until the counts per minute was less than twice the background level. Finally, we determined the specific activity of adducted protein for each sample by scintillation counting and a protein assay ([@b6-ehp-118-647]).

Separation and identification of adducted protein
-------------------------------------------------

Procedures for the separation, localization, and identification of adducted proteins have been described in detail previously ([@b32-ehp-118-647]). Briefly, samples were not pooled, and separate gels were run for each incubation with labeled (for imaging) and unlabeled (for identification) naphthalene. Proteins were resolved by two-dimensional (2D) gel electrophoresis on 18-cm narrow-range pI (isoelectric point) strips for 4.5--5.5 and 5.5--6.7 pI. Strips were rehydrated with 300 μg protein for rat samples or 600 μg protein for monkey samples. Gels containing nonradioactive samples were silver stained and imaged on a 16-bit gray-scale scanner. ^14^C-Labeled sample gels were electroblotted to Sequi-Blot polyvinylidene fluoride membrane (0.2 μm; Bio-Rad), and these were placed against storage phosphor screens for 60 days. The patterns of ^14^C-labeled adducted proteins on the 2D gels were visualized using the GE Typhoon imager (GE Health Care). After excising protein spots of interest from nonradioactive gels, the gel plugs were destained, washed, and incubated in 1:1 (vol/vol) acetonitrile:50 mM ammonium bicarbonate followed by 100% acetonitrile. Tryptic digestion and matrix-assisted laser desorption ionization (MALDI) tandem mass spectroscopy (MS/MS) identification was carried out as described by [@b31-ehp-118-647].

We used GPS Explorer Workstation software (version 3.5; Applied Biosystems, Foster City, CA) and MASCOT (Matrix Sciences, Boston, MA) to search protein databases in the International Protein Index (IPI) rat database (<http://www.ebi.ac.uk/IPI/>), the National Center for Biotechnology Information primate database (NCBI; <http://www.ncbi.nlm.nih.gov/>), and the UniProt database (<http://www.ebi.ac.uk/uniprot/>). Databases were searched for a precursor tolerance of 150 ppm, MS/MS fragment tolerance of 0.2 Da, a maximum of two missed cleavages, and variable modifications for carbamidomethylation and methionine oxidation. An identification with a probability-based MOWSE score \> 60, obtained through MASCOT, was considered statistically significant (*p* \< 0.05).

Results
=======

The specific activities of adducted proteins (nanomoles bound per milligram protein) generated in *in vitro* incubations of nasal epithelium from rats or rhesus macaques varied from 1.0 to 1.5 nmol/mg protein; we noted no statistically significant difference in the data obtained from rat olfactory and septal epithelium compared with rhesus ethmoturbinates and maxilloturbinates ([Figure 1](#f1-ehp-118-647){ref-type="fig"}). Compared with incubations of target airway subcompartments (minor daughter and distal airway) from the mouse ([@b14-ehp-118-647]), the overall levels of adduct generated *in vitro* are slightly lower in rat and monkey nasal epithelial mucosal incubations.

Representative images from the phosphorimaging screens and complementary silver-stained gels/phosphor images indicating the spot locations chosen for MALDI dual time of flight (TOF/TOF) MS analysis are available in Supplemental Material, Figures 1 and 2 (doi:10.1289/ehp.0901333). In general, more adducts were apparent on the images from incubations of rat nasal epithelium than on those from rhesus macaques, but the patterns of major adducts were similar. Spots were matched using the alignment function of Progenesis SameSpots and Progenesis PG220 (version 2006; Nonlinear Dynamics, Durham, NC) matches were manually verified. For identification, we used only those features that could be aligned with the storage phosphor images and selected from the gel with high confidence.

We identified a large number of adducted proteins after incubation of rat nasal olfactory epithelium with naphthalene ([Table 1](#t1-ehp-118-647){ref-type="table"}). These included a number of redundant identifications of structural proteins (actin and tubulin), catalytic proteins (some of which are involved in energy metabolism such as ATP synthase), and a number of proteins involved in the unfolded protein response, including one of the master regulators of that response, glucose regulated protein (heat shock 70 kDa protein 5). In contrast, fewer features were identified from the gels of monkey ethmoturbinates, representing only three nonredundant proteins ([Table 2](#t2-ehp-118-647){ref-type="table"}). Two of these were structural proteins (actin and tubulin), and the third was a protease inhibitor with a myriad of functions.

Discussion
==========

The chronic bioassays conducted by the National Toxicology Program on the potential carcinogenicity of naphthalene in mice ([@b1-ehp-118-647]) and rats ([@b2-ehp-118-647]) have raised concerns about the possible effects of this compound on human health. In mice, an increased incidence of bronchioloalveolar adenoma was observed in females at the highest concentration tested (30 ppm) ([@b1-ehp-118-647]), and in rats, the nasal olfactory epithelium was a prominent target after 105 weeks of exposure ([@b2-ehp-118-647]). [@b33-ehp-118-647] observed dose-dependent increases in adenomas of the respiratory epithelium and a significant increase in olfactory epithelial neuroblastomas in male and female rats, respectively. In the olfactory epithelium, the incidence of hyperplasia and chronic inflammation was nearly 100%, even at the lowest concentration tested (10 ppm). Overall, the high degree of hyperplastic and inflammatory effects and the relative susceptibility of areas of the nasal epithelium after long-term exposures correlate well with the susceptible sites for acute toxicity ([@b29-ehp-118-647]) and raise the possibility that the tumorigenic effects of naphthalene observed in animals are related to repeated cycles of injury and repair ([@b39-ehp-118-647]).

The published assessments by regulatory bodies on the potential carcinogenicity of naphthalene in humans differ (e.g., [@b25-ehp-118-647]; [@b37-ehp-118-647]). Although the toxicologic data in animals are very clear, human epidemiologic studies in populations of exposed workers are uninformative. In most short-term mutagenicity assays, naphthalene is negative (reviewed by [@b8-ehp-118-647]). Recent evidence for the formation of DNA adducts comes both from *in vitro* studies with naphthalene metabolites ([@b45-ehp-118-647]) and from skin-painting studies using both naphthalene and naphthalene metabolites ([@b44-ehp-118-647]). The skin-painting studies demonstrated the presence of both depurinating and stable adducts, suggesting that this may be a possible mechanism for tumorigenesis associated with naphthalene in rodent models.

Previous studies demonstrating 10- to 100-fold differences in the rates of pulmonary microsomal formation of glutathione conjugates of naphthalene between rodents and human/nonhuman primates ([@b11-ehp-118-647]; [@b9-ehp-118-647]) and in dissected airways of rodents and nonhuman primates ([@b5-ehp-118-647]; [@b12-ehp-118-647]) suggested that humans would be considerably less susceptible to naphthalene than are rodents. Although the dramatic differences in susceptibility to naphthalene of airway epithelium in the mouse and rat appear to be related to metabolism of naphthalene by CYP2F, recent work showing that several human CYPs can metabolize naphthalene with high efficiency suggests that other CYP enzymes may catalyze the turnover of this substrate in humans ([@b15-ehp-118-647]; [@b21-ehp-118-647]). In particular, CYP2A13, which has been reported in both lung and nasal epithelium of humans (for review, see [@b18-ehp-118-647]), shows a *K*~m~ of 36 μM and high catalytic efficiency with naphthalene. In addition, our finding of similar levels of covalent protein binding in nasal epithelium of the rodent and monkey ([Figure 1](#f1-ehp-118-647){ref-type="fig"}), as well as observations that some (but not all) of the proteins adducted by reactive metabolites of naphthalene are the same in dissected airways and nasal epithelium of rodents and nonhuman primates ([@b32-ehp-118-647], [@b31-ehp-118-647]; see also [Tables 1](#t1-ehp-118-647){ref-type="table"} and [2](#t2-ehp-118-647){ref-type="table"}), supports the need for additional studies on the possible sensitivity of humans to naphthalene exposure.

The concept that posttranslational modification of proteins by electrophiles begins a series of events leading to cellular necrosis was proposed by [@b7-ehp-118-647] some 40 years ago, and was supported by studies showing correlations between overall electrophile protein adduct formation and toxicity (for a recent review, see [@b23-ehp-118-647]). The advent of new MS techniques coupled with 2D gel electrophoresis has resulted in the identification of numerous protein targets for cytotoxic agents that require metabolic activation; a current database of these targets shows many commonalities ([@b20-ehp-118-647]). Despite these efforts, a final unifying hypothesis tying the adduction of specific proteins with toxicity has not emerged, and additional work is needed to answer several questions. In those cases where adduction occurs to an abundant protein, is this protein simply acting as a sink to trap electrophiles? Does the formation of an adduct with an individual protein alter the function of that protein directly, or is the deleterious effect mediated by protein-interacting partners? These will clearly be challenging questions but, if solved, could greatly enhance our ability to more quickly and precisely assess the human risk of exposure to agents that undergo metabolic activation to protein-reactive electrophiles.

As noted above, much of the progress in identifying proteins targeted by reactive metabolites has derived from the application of 2D gel electrophoresis and more rapid MS-based identifications. Although 2D gel electrophoresis arguably provides the greatest resolving power for whole proteins of any separations technique available, there is still the potential of selecting a spot that contains two unseparated proteins, one that is low abundance and adducted and one that is much higher abundance and identified by MS. Although we cannot exclude this as a possibility in the present study, we used IPG strips with very narrow ranges to lessen the potential for misidentification. In only one case that we are aware of---with thiobenzamide---were the investigators able to show that the features removed from the gel were adducted by using isotope ratios with equal quantities of hydrogen/deuterium-labeled substrate ([@b24-ehp-118-647]). This was likely possible only because the adduct levels generated from thiobenzamide are considerably greater than those for other metabolically activated toxicants.

In the present study, adducts with the structural proteins actin and tubulin were isolated from both rat and monkey nasal epithelial incubations. These are high-abundance proteins in the cell that have been identified in several other studies as common targets for other reactive metabolites, including butylated hydroxytoluene (BHT) ([@b36-ehp-118-647]), benzene ([@b51-ehp-118-647]), thiobenzamide ([@b24-ehp-118-647]), and the model thiol-reactive electrophiles biotinyl-iodoacetamidyl-3,6-dioxaoctanediamine and 1-biotinamido-4-(4′\[maleidoethylcyclohexane\]-carboxyamido)butane ([@b17-ehp-118-647]). The formation of covalent adducts with actin and tubulin is not generally considered to be a critical step in the pathway to cellular injury because the specific activity of these adducted proteins (nanomoles bound per nanomole of protein) is likely to be quite low. However, one of the earliest signs of cellular disruption in naphthalene-treated mice involves the formation of apical membrane blebs and apparent disruption of cytoplasmic filaments ([@b49-ehp-118-647]). Similar signs of disruption of cytoskeletal elements have been noted in airway epithelial cells after administration of diethyl maleate, but these changes resolved and did not lead to frank necrosis ([@b41-ehp-118-647]). This is consistent with previous work showing that *S*-glutathionylation of cysteine-374 of actin reduces the rate of polymerization of this structural molecule ([@b16-ehp-118-647]) and that glutathionylation of this protein leads to decreased affinity of its partner protein tropomyosin ([@b13-ehp-118-647]). Both naphthalene and diethyl maleate substantially deplete glutathione levels in airway epithelium, which may result in increased levels of glutathionylated actin. Reactive metabolites from naphthalene produce a double hit on actin and tropomyosin, resulting in both thiolation reactions (which are reversible) and covalent arylation reactions (which presumably are not). Ongoing work in our laboratory is evaluating the protein targets of diethyl maleate as a mechanism for distinguishing adducts that may be critical to cellular injury from those that are not.

We observed a potentially important group of protein targets in nasal olfactory epithelial incubations from the rat but not from the monkey; these proteins are responsible for protein folding and repair in the cell. Glutathione depletion is a necessary but insufficient prelude to naphthalene cytotoxicity. The loss of this key thiol leaves the cell vulnerable to intracellular reactive oxygen species that, with diethyl maleate, can be corrected by chaperones, protein disulfide isomerase, peroxiredoxins, and possibly several other proteins involved in antioxidant protection and protein folding. With naphthalene, several of these proteins, including the master regulator of the unfolded protein response, BiP/GRP78 (78 kDa glucose- regulated protein) ([@b48-ehp-118-647]), as well as the heat shock proteins HSP60 and HSP70, are adducted, thus potentially altering their ability to repair proteins undergoing thiol oxidation and unfolding during the early stages of naphthalene toxicity. This is consistent with findings showing marked up-regulation of the HSPs in mouse lung at early times after naphthalene treatment ([@b52-ehp-118-647]). An interesting but unproven link in possible mechanisms comes from recent work demonstrating that proteins involved in the unfolded protein response are substantially up-regulated in smokers compared with former smokers and nonsmokers ([@b26-ehp-118-647]).

The present study provides a list of potential protein targets and shows that some of these are similar in nasal epithelium of the rat (a known target for naphthalene toxicity) and that of the rhesus macaque. We derived several other adducted proteins from monkey nasal epithelial incubations, but these yielded unreliable identifications. We are working on methods for concentrating adducted proteins to provide greater sensitivity for these analyses. In the future, it will be important to gain additional insight regarding critical versus noncritical protein adduction. Part of this information will come from studies such as that published by [@b35-ehp-118-647], which showed that metabolites of BHT alkylate key antioxidant enzymes and that the alkylation resulted in a decrement in enzyme function that, in turn, was consistent with the biological responses after BHT treatment.

In the present study we focused on protein adducts that are most likely related to acute cellular injury. Whether repeated cycles of injury and repair with subsequent hyperplasia are related to naphthalene tumorigenicity will need additional study. Finally, the possibility that exposure to naphthalene and other similar, volatile polycyclic aromatic hydrocarbons (PAHs) could produce lung disease other than cancer should be explored. In this regard, limited studies have reported correlations between serum levels of naphthalene and pyrene, but not other PAHs, with asthma incidence in children ([@b3-ehp-118-647]). Moreover, there is a clear association of exposure to traffic-related pollution and asthma ([@b27-ehp-118-647]), and naphthalene is the most prevalent PAH in this mixture ([@b34-ehp-118-647]). Recent work showing that polymorphisms that result in alterations in enzymatic activities for two key enzymes involved in the metabolism of PAHs (microsomal epoxide hydrolase and glutathione transferase pi) lead to increased incidence of asthma in children living near freeways ([@b46-ehp-118-647]) provide an interesting but unsubstantiated link between PAHs in motor vehicle exhaust and asthma. The understanding of target proteins and their relationship to the pathology from naphthalene in animals should improve our ability to assess the possible risks of this compound in exposed human populations.

Conclusion
==========

This study shows that the amounts of covalent adduct generated from naphthalene in incubations of rhesus nasal epithelium are similar to those formed using rat olfactory and septal nasal epithelium, two sites known to be susceptible to the cytotoxicity associated with naphthalene. Many of the adducted proteins identified are the same as those observed in incubations with other target tissues. Our results are consistent with the view that nasal epithelium of the rhesus macaque may be susceptible to naphthalene cytotoxicity.

Supplemental Material is available online (doi:10.1289/ehp.0901333 via <http://dx.doi.org/>).
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![Covalent reactive metabolite binding to protein in rat, rhesus, and mouse tissue. Abbreviations: ethmo, ethmoturbinate; Maj D, major daughter; max, maxilloturbinate; Min D, minor daughter. Fresh samples of rat septum (*n* = 3), rat olfactory ethmoturbinate (*n* = 3), rhesus maxilloturbinate (*n* = 8), and rhesus ethmoturbinate (*n* = 8) were incubated with ^14^C-naphthalene (250 μM) for 2 hr at 37°C for determination of the levels of covalent reactive metabolite binding to protein. Values are mean ± SD. Reference values for tissue subcompartments of mouse lung are from [@b14-ehp-118-647].](ehp-118-647f1){#f1-ehp-118-647}

###### 

Adducted proteins identified from incubation of rat olfactory ethmoturbinate with ^14^C-naphthalene.

  Gel spot   Protein name (abbreviated)                        MOWSE score[a](#tfn1-ehp-118-647){ref-type="table-fn"}   Peptide count[b](#tfn2-ehp-118-647){ref-type="table-fn"}   Protein score CI%[c](#tfn3-ehp-118-647){ref-type="table-fn"}   Accession no.[d](#tfn4-ehp-118-647){ref-type="table-fn"}   Protein MW (Da)   Protein pI   Summary of function
  ---------- ------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------- -------------------------------------------------------------- ---------------------------------------------------------- ----------------- ------------ ------------------------------------------------------------------------------
  N1         Sorcin (P30626)                                   133                                                      5                                                          100                                                            SORCN CRILO[e](#tfn5-ehp-118-647){ref-type="table-fn"}     22017.4           5.32         Calcium-binding protein
  N4         Golgi autoantigen                                 90                                                       24                                                         99.951                                                         GI: 808869[f](#tfn6-ehp-118-647){ref-type="table-fn"}      372014.8          4.96         May participate in forming intercisternal cross bridges of the Golgi complex
  N7         pyruvate dehydrogenase                            69                                                       7                                                          99.596                                                         ODPB_RAT[e](#tfn5-ehp-118-647){ref-type="table-fn"}        39,336            5.94         Glycolysis
  N8         mu-crystallin                                     135                                                      4                                                          100                                                            IPI00214448                                                33704.1           5.34         Ammonia elimination
  N9         pyrophosphatase                                   67                                                       7                                                          99.283                                                         IPI00371957                                                33206.3           5.26         Signal transduction
  N12        creatinine kinase                                 543                                                      20                                                         100                                                            IPI00470288                                                42983.4           5.39         Energy transduction
  N13        Sec 1413 protein                                  131                                                      6                                                          100                                                            IPI00208939                                                46453.5           5.64         Hydrophobic ligand binding
  N19        creatinine kinase                                 299                                                      10                                                         100                                                            IPI00470288                                                42983.4           5.39         Energy transduction
  N23        actin                                             259                                                      10                                                         100                                                            IPI00369618                                                59162.6           5.67         Structural
  N24        eukaryotic translation initiation factor 4A1      129                                                      14                                                         100                                                            IPI00369618                                                46352.6           5.32         Protein synthesis initiation
  N25        beta actin                                        447                                                      10                                                         100                                                            GI: 62897625[f](#tfn6-ehp-118-647){ref-type="table-fn"}    41737.8           5.37         Structural
  N26        actin, cytoplasmic                                420                                                      15                                                         100                                                            IPI00767505                                                42108.9           5.31         Structural
  N27        actin                                             753                                                      17                                                         100                                                            IPI00194087                                                42,334            5.23         Structural
  N29        actin, cytoplasmic                                198                                                      6                                                          100                                                            IPI00765011                                                59162.6           5.67         Structural
  N32        actin, cytoplasmic                                167                                                      4                                                          100                                                            IPI00765011                                                59162.6           5.67         Structural
  N33        actin, cytoplasmic                                186                                                      5                                                          100                                                            IPI00765011                                                59162.6           5.67         Structural
  N41        ATP synthase                                      919                                                      21                                                         100                                                            IPI00551812                                                56318.5           5.19         ATP catabolism
  N43        ATP synthase                                      160                                                      17                                                         100                                                            IPI00551812                                                56318.5           5.19         ATP catabolism
  N47        heat shock protein 1A (chaperonin) (Hsp 60)       220                                                      27                                                         100                                                            IPI00339148                                                61088.4           5.91         Stress-induced chaperone; protein folding
  N51        heat shock 70 kDa 9 A (predicted)                 419                                                      9                                                          100                                                            IPI00363265                                                74,097            5.97         Protein folding; protein export; binds ATP, nucleotides, and proteins
  N53        heat shock 70 kDa 9 A (predicted)                 64                                                       5                                                          98.428                                                         IPI00858386                                                74098.9           5.97         Protein folding; protein export; binds ATP, nucleotides, and proteins
  N55        Vomeromodulin                                     87                                                       8                                                          99.992                                                         IPI00209782                                                79527.3           5.92         Putative pheromone and odorant transporter
  N56        heat shock 70 kDa, protein 5                      621                                                      15                                                         100                                                            IPI00206624                                                72473.5           5.07         Assembly of multimeric protein complexes
  N57        heat shock 70 kDa, protein 5                      896                                                      27                                                         100                                                            IPI00206624                                                72473.5           5.07         Assembly of multimeric protein complexes
  N61        tyrosine 3-mono-oxygenase Tryptophan 5            243                                                      12                                                         100                                                            IPI00230835                                                28,456            4.8          Adapter protein; signal transduction
  N63        tubulin                                           485                                                      12                                                         100                                                            IPI00189795                                                50787.9           4.94         Structural
  N64        tubulin                                           174                                                      16                                                         100                                                            IPI00339167                                                50119.6           4.94         Structural
  N65        tubulin                                           148                                                      14                                                         100                                                            IPI00339167                                                50119.6           4.94         Structural
  N66        tubulin                                           258                                                      23                                                         100                                                            IPI00400573                                                49,769            4.79         Structural
  N67        tubulin                                           464                                                      24                                                         100                                                            IPI00197579                                                49,639            4.78         Structural
  N68        protein disulfide isomerase                       272                                                      17                                                         100                                                            IPI00198887                                                56915.7           4.82         Cell redox homeostasis
  N69        protein disulfide isomerase                       139                                                      15                                                         100                                                            IPI00198887                                                56915.7           4.82         Cell redox homeostasis
  N70        protein disulfide isomerase                       227                                                      25                                                         100                                                            IPI00198887                                                56915.7           4.82         Cell redox homeostasis
  N73        ubiquinol-cytochrome c reductase core protein 1   162                                                      16                                                         100                                                            IPI00471577                                                57815.4           5.57         Mitochondrial electron transport
  N74        ubiquinol-cytochrome c reductase core protein 1   78                                                       19                                                         99.939                                                         IPI00471577                                                52815.4           5.57         Mitochondrial electron transport
  N75        chloride intracellular channel 1                  212                                                      14                                                         100                                                            IPI00421995                                                26963.8           5.09         Macrophage activation
  N76        tubulin                                           166                                                      12                                                         100                                                            IPI0018975                                                 5103.6            4.94         Structural
  N77        tubulin                                           126                                                      19                                                         100                                                            IPI00400573                                                49,769            4.79         Structural

The probability-based MOWSE score from MASCOT.

Peptides used for matching within the database.

Reflects the probability that this same match would be made in a different database.

Accession numbers are from the IPI rat database except where noted.

From the Swiss-Prot database searching mammals.

From the NCBI database searching mammals.

###### 

Adducted proteins identified from incubations of monkey ethmoturbinate with ^14^C-naphthalene.

  Gel spot   Protein name (abbreviated)   MOWSE score[a](#tfn7-ehp-118-647){ref-type="table-fn"}   Peptide count[b](#tfn8-ehp-118-647){ref-type="table-fn"}   Protein score CI[c](#tfn9-ehp-118-647){ref-type="table-fn"}   Accession no.[d](#tfn10-ehp-118-647){ref-type="table-fn"}   Protein MW (Da)   Protein pI   Function
  ---------- ---------------------------- -------------------------------------------------------- ---------------------------------------------------------- ------------------------------------------------------------- ----------------------------------------------------------- ----------------- ------------ ------------
  M1         actin                        333                                                      22                                                         100                                                           P60709                                                      40978.4           5.56         Structural
  M2         actin                        628                                                      25                                                         100                                                           GI: 62897625                                                41737.8           5.37         Structural
  M3         actin                        526                                                      23                                                         100                                                           P60709                                                      40978.4           5.56         Structural
  M4         tubulin                      95                                                       17                                                         99.992                                                        GI: 114627728                                               7398.9            4.72         Structural
  M5         actin                        107                                                      11                                                         100                                                           P68133                                                      37799.8           5.39         Structural
  M6         actin                        469                                                      18                                                         100                                                           Q8WvW5                                                      40477.2           5.78         Structural
  M7         actin                        690                                                      23                                                         100                                                           GI: 4501883                                                 41981.8           5.23         Structural
  M8         actin                        479                                                      20                                                         100                                                           GI: 4501883                                                 41981.8           5.23         Structural
  M9         actin                        181                                                      13                                                         100                                                           GI: 4885049                                                 41981.9           5.23         Structural
  M10        actin                        147                                                      10                                                         100                                                           GI: 149758067                                               37799.8           5.39         Structural
  M11        fibrinogen                   162                                                      12                                                         100                                                           GI: 109075971                                               36492.6           5.61         Various
  M12        protease inhibitor           514                                                      22                                                         100                                                           GI: 109084715                                               46669.9           5.55         Various
  M13        actin                        528                                                      23                                                         100                                                           GI: 15277503                                                40194.1           5.55         Structural
  M14        actin                        588                                                      26                                                         100                                                           GI: 62897671                                                41693.7           5.29         Structural
  M15        tubulin                      455                                                      25                                                         100                                                           GI: 18088719                                                49639.9           4.75         Structural
  M16        tubulin                      253                                                      20                                                         100                                                           GI: 23958133                                                49808             4.83         Structural
  M17        actin                        226                                                      15                                                         100                                                           GI: 14250401                                                40978.9           5.56         Structural
  M18        tubulin                      338                                                      20                                                         100                                                           GI: 114627728                                               47398.9           4.72         Structural
  M19        actin                        491                                                      19                                                         100                                                           GI: 4885049                                                 41991.9           5.23         Structural
  M20        tubulin                      314                                                      15                                                         100                                                           GI: 109096498                                               42214.1           4.94         Structural
  M21        protease inhibitor           106                                                      11                                                         100                                                           GI: 109069435                                               42214.1           5.08         Various

The probability-based MOWSE score from MASCOT.

Peptides used for matching within the database.

Reflects the probability that this same match would be made in a different database.

From the NCBI database searching mammals.
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